31 August 2017 - - The global electrophysiology therapeutic devices market is forecast to grow at a CAGR of 9.38% during the period 2017-2021, according to a report from Dublin-based Research and Markets.

According to the report, one driver in the market is increasing incidence of cardiac arrhythmia cases. Cardiac arrhythmia is the abnormal rhythm of the heart or irregular heartbeat resulting due to tachycardia (faster heart beat), bradycardia (slower heartbeat), stroke, or cardiac arrest.

Cardiac ablation is used as a corrective measure for treating cardiac arrhythmia. EP therapeutic devices are used to monitor the heart beat and facilitate the treatment of the abnormal heart function.

The growing incidence of cardiac arrhythmia and CVD cases is driving the growth of many market segments in the EP devices market such as ECG devices, pacemakers, CRT devices, and ablation catheters.

Key players in this market include Boston Scientific, Medtronic and St. Jude Medical.